Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN105906576A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN105906576A offers toxic-free lesinurad intermediate synthesis. High yield 96.30% step ensures cost reduction and supply reliability for pharmaceutical manufacturing.